Breaking News Instant updates and real-time market news.

PII

Polaris Industries

$97.77

-1.155 (-1.17%)

07:41
04/24/19
04/24
07:41
04/24/19
07:41

Polaris Industries price target raised to $101 from $83 at Wedbush

Wedbush analyst James Hardiman raised his price target for Polaris Industries to $101 from $83, while reiterating a Neutral rating on the shares. The analyst notes that Q1 was a soft quarter from a retail perspective, with weather and share losses hurting the key ORV segment. However, he believes the weather headwinds were fairly well understood, with the incremental information primarily consisting of a strong finish to March and a strong start to April.

  • 25

    Apr

PII Polaris Industries
$97.77

-1.155 (-1.17%)

04/08/19
04/08/19
UPGRADE
Target $125

Overweight
Polaris Industries upgraded to Overweight on new product, tariffs at KeyBanc
As previously reported, KeyBanc analyst Brett Andress upgraded Polaris Industries to Overweight from Sector Weight, with a $125 price target. The analyst sees a favorable risk/reward developing given increased evidence that the company will meaningfully refresh its RZR line this year, driving outsized retail gains into FY20. Further, he believes Polaris Industries stands to benefit the most in his coverage should tariffs eventually make progress, providing additional optionality.
04/24/19
GSCO
04/24/19
INITIATION
Target $123
GSCO
Buy
Polaris Industries initiated with a Buy at Goldman Sachs
Goldman Sachs analyst David Tamberrino started Polaris Industries with a Buy rating and $123 price target. The company maintains the top share in powersports, and its recent research and development investments should start yielding benefits, Tamberrino tells investors in a research note. He expects Polaris' 2019 new product introduction to be "robust" and help the company regain market share.
04/24/19
GSCO
04/24/19
INITIATION
Target $35
GSCO
Neutral
BRP Inc. initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst David Tamberrino started BRP Inc. (BRP) with a Neutral rating and $35 price target. The company's future market share gains will be more difficult with Polaris Industries (PII) focusing more aggressively on its product cycle, Tamberrino tells investors in a research note. Further, he thinks BRP's cost savings "may be topped out."
04/24/19
GSCO
04/24/19
DOWNGRADE
Target $34
GSCO
Sell
Goldman downgrades 'worst positioned' Harley-Davidson to Sell from Neutral
Goldman Sachs analyst David Tamberrino downgraded Harley-Davidson (HOG) to Sell from Neutral and lowered his price target for the shares to $34 from $37. The stock closed yesterday down 78c to $38.92. The analyst views Harley as the "worst positioned" within his Powersports coverage given its concentration in a "secularly declining" motorcycle market. The company needs to grow its customer-base through rider academies as well as incremental marketing spend, Tamberrino tells investors in a research note. Further, Harley-Davidson's new product introductions into more crowded markets will likely lower its margins. While Harley's move into smaller bikes and electrification has longer-term benefits, the strategy could hurt profitability given the requirements for incremental spend, says the analyst. Lastly, Tamberrino sees risk to Harley-Davidson Financial Services as interest rates rise. The analyst this morning also initiated coverage of Polaris Industries (PII) with a Buy rating and BRP Inc. (DOOO) with a Neutral rating.

TODAY'S FREE FLY STORIES

DLX

Deluxe

$40.14

-0.77 (-1.88%)

06:43
06/25/19
06/25
06:43
06/25/19
06:43
Conference/Events
Deluxe management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AKAM

Akamai

$78.70

0.13 (0.17%)

, FSLY

Fastly

$17.49

-0.775 (-4.24%)

06:43
06/25/19
06/25
06:43
06/25/19
06:43
Recommendations
Akamai, Fastly analyst commentary  »

CDN Tracker data positive…

AKAM

Akamai

$78.70

0.13 (0.17%)

FSLY

Fastly

$17.49

-0.775 (-4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Host Hotels initiated  »

Host Hotels initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Park Hotels & Resorts initiated  »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEB

Pebblebrook Hotel

$27.31

-1.175 (-4.13%)

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Pebblebrook Hotel initiated  »

Pebblebrook Hotel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLE

Apple Hospitality REIT

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Apple Hospitality REIT initiated  »

Apple Hospitality REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$17.56

-0.28 (-1.57%)

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
RLJ Lodging Trust initiated  »

RLJ Lodging Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INN

Summit Hotel Properties

$11.30

-0.14 (-1.22%)

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Summit Hotel Properties initiated  »

Summit Hotel Properties …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$160.88

-4.43 (-2.68%)

06:35
06/25/19
06/25
06:35
06/25/19
06:35
Periodicals
FedEx sues government over enforcement of China export ban, Reuters reports »

FedEx has sued the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:33
06/25/19
06/25
06:33
06/25/19
06:33
Periodicals
AbbVie near deal to buy Allergan for $188 per share in cash and stock, WSJ says »

AbbVie (ABBV) is closing…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

CODX

Co-Diagnostics

$0.74

-0.0295 (-3.86%)

06:33
06/25/19
06/25
06:33
06/25/19
06:33
Hot Stocks
Co-Diagnostics launches Logix Smart ZDC multiplex test »

Co-Diagnostics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BW

Babcock & Wilcox

$0.41

0.0263 (6.85%)

06:32
06/25/19
06/25
06:32
06/25/19
06:32
Hot Stocks
Babcock & Wilcox sells Loibl to subsidiary of Deutsche Invest Mittelstand »

Babcock & Wilcox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$80.55

-0.18 (-0.22%)

, CIR

Circor

$45.77

-0.03 (-0.07%)

06:32
06/25/19
06/25
06:32
06/25/19
06:32
Hot Stocks
Crane refutes Circor's plan, urges shareholders to tender shares »

Crane (CR) filed a…

CR

Crane

$80.55

-0.18 (-0.22%)

CIR

Circor

$45.77

-0.03 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:28
06/25/19
06/25
06:28
06/25/19
06:28
Periodicals
Breaking Periodicals news story on Allergan, AbbVie »

AbbVie would pay $188 per…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:27
06/25/19
06/25
06:27
06/25/19
06:27
Periodicals
Breaking Periodicals news story on Allergan, AbbVie »

AbbVie near deal to…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

PT

Pintec Technology

$2.98

-0.13 (-4.18%)

06:27
06/25/19
06/25
06:27
06/25/19
06:27
Hot Stocks
Pintec Technology announces strategic partnership with Bank of Ganzhou »

Pintec Technology inked a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$36.08

-0.12 (-0.33%)

06:24
06/25/19
06/25
06:24
06/25/19
06:24
Hot Stocks
Dr. Reddy's launches its Tobramycin Inhalation Solution »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$28.91

-0.17 (-0.58%)

06:21
06/25/19
06/25
06:21
06/25/19
06:21
Periodicals
JD.com's logistics unit raises $218M investment fund, Reuters reports »

The logistics division of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$311.63

-15.05 (-4.61%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Downgrade
Shopify rating change at Wedbush »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CBMG

Cellular Biomedicine

$15.01

(0.00%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$47.63

0.17 (0.36%)

06:18
06/25/19
06/25
06:18
06/25/19
06:18
Periodicals
Intel plans to cut desktop processor prices by up to 15%, DigiTimes reports »

Intel is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

06:15
06/25/19
06/25
06:15
06/25/19
06:15
Periodicals
U.S.: Turkey would lose F-35 if Russia arms deal moves forward, Reuters says »

The U.S. cannot allow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

06:12
06/25/19
06/25
06:12
06/25/19
06:12
Periodicals
Nissan overhauls board following disorderly investor meeting, WSJ reports »

Nissan investors voted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVTL

Pivotal Software

$11.35

-0.15 (-1.30%)

06:11
06/25/19
06/25
06:11
06/25/19
06:11
Downgrade
Pivotal Software rating change at BofA/Merrill »

Pivotal Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

06:08
06/25/19
06/25
06:08
06/25/19
06:08
Periodicals
Alphabet's Sidewalk Labs meets resistance over Toronto plans, WSJ reports »

Sidewalk Labs, a unit of…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.